Esprolol, formerly known as ACC-9369, is a β-adrenergic receptor antagonist potentially for the treatment of angina pectoris, anxiety and migraine. Esprolol has potential for short-term use in patients with exertional angina and in patients with other diseases in which rapid-onset beta blocking action would be beneficial. References: Matier WL, Patil G. Esprolol hydrochloride: a new beta adrenergic antagonist with a rapid onset of effect. Heart Dis. 2000 Mar-Apr;2(2):146-50. PubMed PMID: 11728252.

纯度：≥98%

CAS：112805-65-9